Biotech Investors & VC Firms in Asia-Pacific
746 firms in this list, with a median first check of $500K. 161 of them lead rounds. Generated from verified public data and updated continuously.
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
Clay Capital
Seed–Series C$3M – $8M
18 people
Green Pine Capital Partners
ShenzhenPre-Seed–Series B
2 people
Tenmile
Seed–Growth
11 people
Hundreds Capital
BeijingGrowth
3 people
MedTech Actuator
Seed–Series B
DFJ DragonFund
ShanghaiSeed–Series B
10 people
Gandel Invest
MelbourneGrowth
10 people
Chartered Group
TokyoSeed
23 people
Sprout
Palmerston NorthPre-Seed–Seed
20 people
EFung Capital
ShenzhenSeries A–Growth
1 person
Innovation Engine
TokyoSeed–Late Stage
19 people
Pix Vine Capital
SingaporeSeed–Series A$250K – $500K
1 person
Puhua Capital
HangzhouPre-Seed–Growth
INCE Capital
ShanghaiSeed–Growth
12 people
Waseda University Ventures
TokyoPre-Seed–Seed
15 people
Cicada Innovations
EveleighSeed–Series A
23 people
IAN Fund
Seed–Series A
14 people
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $5M
19 people
Shastra VC
Pre-Seed–Seed
11 people
GSR United Capital
BeijingSeed–Growth
Everstone Capital Asia Pte. Ltd.
Singapore
22 people
Merak Ventures
New DelhiPre-Seed–Series A$500K – $1.5M
7 people
Nextblue
TokyoPre-Seed–Series A$70K – $700K
4 people
Related lists
Investors & VC Firms in North America (13321)Investors & VC Firms in United States (12313)Investors & VC Firms in Europe (6087)AI & Machine Learning Investors & VC Firms (5355)Investors & VC Firms in Global (5320)Fintech Investors & VC Firms (5141)Healthtech Investors & VC Firms (4658)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4426)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.






























































